Industry Verticals »

All Categories

Insights »

About TMR »

Collagen and HA-based Biomaterials Market

Collagen and HA-based Biomaterials Market (Type: Urinary Incontinence, Corneal Shields, Facial Aesthetic Dermal Fillers, Wound Dressings, and Others; Application: Food, Medicine, Cosmetics, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Collagen and HA-based Biomaterials Market – Need for Enhancing Patient Outcomes Driving Engine for Innovation 

Facial aesthetic treatments, in recent years, have been focused on high quality results with minimal steps involved. And while for years, collagen and hyaluronic acid (HA)-based biomaterials have been used for improving would healing and cosmetic surgeries, currently, there has been a flurry of activity, all aimed at enhancing patient outcomes. These innovations include several advanced dermal fillers that have been developed to cater to the skincare needs of people, globally. For instance, in May 2018, Nestlé Skin Health’s dermal filler Restylane® Lyft was approved by the Food and Drug Association for aesthetic and cosmetic purposes. According to this recent study by Transparency Market Research (TMR), the collagen and HA-based biomaterials market is set to grow at an average CAGR of ~5% during the forecast period of 2019 to 2027. The study projects a rise in investments toward research & development (R&D) that are predominantly aimed at discovering collagen and HA-based biomaterials that can be used in next-generation, innovative products such as injectable dermal fillers, in various cosmetic surgeries.

collagen ha based biomaterials market infographic

To know the scope of our report Get a Sample on Collagen and HA-based Biomaterials Market 

Adoption of Collagen and HA-based Biomaterials to Grow Beyond Cosmetic Surgeries 

There has been a rise in the number of cosmetic surgeries around the globe, in recent years, due to technological advancements and the launching of new & effective products. Nevertheless, collagen and hyaluronic acid-based biomaterials are also being increasingly used in the treatment of chronic diseases such as diabetes, degenerative joint disorders, and skin infections, which is also a major driver of the global collagen and HA-based biomaterials market. 

The advantages that are offered by collagen include stability, even as it stimulates tissue growth, which is being leveraged by manufacturers to provide better treatment options for orthopaedic care and wound care. Manufacturers are also increasingly focusing on the medical needs of patients with joint- and mobility-related issues, the increasing prevalence of which is likely to cause significant economic burden, globally.

Get a glimpse of the in-depth analysis through our Report Brochure

According to this study on the global collagen and HA-based biomaterials market, the adoption of collagen for wound dressings is contributing to the healthy growth of its application in medicine, which is estimated to capture around one-fourth of the total share of the global collagen and hyaluronic acid-based biomaterials market by 2027. The study also finds that, in 2018, facial aesthetic dermal fillers occupied the largest share by way of revenue in the global collagen and HA-based biomaterials market, and this is likely to continue over the forecast period. This can be attributed to the demand for HA-based dermal fillers for the improvement of facial aesthetics, as well as in applications beyond cosmetic surgeries. 

Demand for Animal-derived Collagen to Decline Due to Religious Concerns 

With animal-derived constituents progressively becoming a part of healthcare, especially in the case of collagen sources, religious and cultural beliefs are increasingly hampering the acceptance and adoption of collagen and hyaluronic acid-based biomaterials. Pigs and cows are a rich source of collagen, and the usage of products derived from these sources is problematic in different regional markets, as such, negatively impacting the growth of the global collagen and HA-based biomaterials market.

collagen ha based biomaterials market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint 

Authors of this report estimate that, the collagen and HA-based biomaterials market will grow at an average pace during the forecast years. This is expected to come on the back of the rising popularity of cosmetic surgeries, with players in the market competing aggressively in the global landscape with new product launches and innovations. Stakeholders should focus on R&D into alternatives to animal-derived constituents, from synthetic sources, to boost their popularity, and therefore, the adoption of collagen and HA-based biomaterials in cosmetics and healthcare. 

Of the regional markets in the global collagen and HA-based biomaterials market, North America is expected to continue to hold the largest share by revenue, due to better healthcare facilities in the region. However, the market in Asia Pacific is also brimming with opportunities for manufacturers to capitalise on, as the region witnesses an increased geriatric population suffering from degenerative joint disorders.

Global Collagen and HA-based Biomaterials Market: Introduction

  • Collagen is one of the most abundant form of protein in the human body, and the use of this biomaterial in tissue engineering has increased extensively, owing to its easy availability, biodegradability, versatility, and biocompatibility.
  • The application of exogenous hyaluronan and hyaluronan-based biomaterials has been successful in wound healing, cosmetic surgeries, food packing & ingredients, and a number of other medical disciplines such as dermatology, rheumatology, and ophthalmology
  • Rise in cosmetic procedures across the globe, technological advancements, launch of new collagen-based products in developed regions, increase in the prevalence of joint disorders worldwide, and advantages offered by HA-based biomaterials are anticipated to drive the global collagen and HA-based biomaterials market during the forecast period.
  • The global collagen and HA-based biomaterials market was valued at ~US$ 6 Bn in the years 2018, and is anticipated to reach a value of ~US$ 9.7 Bn by 2027, expanding at a CAGR of ~5% from 2019 to 2027.
  • North America, Europe, and Asia Pacific were the major markets for collagen and HA-based biomaterials in 2018. The collagen and HA-based biomaterials market in Asia Pacific is expected to expand at a high CAGR of ~6% during the forecast period.

Collagen and HA-based Biomaterials Market: Overview

  • Biomaterials are one of the most vital materials used in healthcare and pharmaceutical industries. Collagen and HA-based biomaterials are widely used in tissue engineering due to their wide availability, biodegradability, and biocompatibility. Collagen and HA-based biomaterials have potential application in the fields of regenerative medicine, food industry, personal healthcare, and development of prosthetics.
  • Rapid technological advancements, significant new product launches by industry players, surge in cosmetic procedures, and advantages offered by collagen and HA-based biomaterials are likely to fuel the growth of the global collagen and HA-based biomaterials market during the forecast period.
  • North America held a major share of the global collagen and HA-based biomaterials market in 2018, due to the wide acceptance and availability of collagen and HA-based biomaterials, and rise in hyaluronic acid dermal filler procedures performed in the U.S.
  • The collagen and HA-based biomaterials market in Asia Pacific is expected to expand at a CAGR of ~6% from 2019 to 2027, due to an increase in the usage of collagen-enriched face masks, HA-based dermal fillers, and other cosmetic products.

Collagen and HA-based Biomaterials Market: Key Segments

  • In terms of type, the global collagen and HA-based biomaterials market has been segmented into urinary incontinence, corneal shields, facial aesthetic dermal fillers, wound dressings, and others The facial aesthetic dermal fillers segment accounted for a major share of the collagen and HA-based biomaterials market in 2018, and the trend is anticipated to continue during the forecast period.
  • Based on application, the global collagen and HA-based biomaterials market has been categorized into food, medicine, cosmetics, and others. The cosmetics segment accounted for a major share of the market in 2018. 

Collagen and HA-based Biomaterials Market: Prominent Companies

  • Key players in the global collagen and HA-based biomaterials market have been profiled based on attributes, such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies.
  • Major companies profiled in the global collagen and HA-based biomaterials market report are
    • Galderma Laboratories L.P. (Nestle Skin Health)
    • Allergan plc
    • Collagen Solutions Plc
    • Anika Therapeutics, Inc.
    • Johnson & Johnson Services, Inc.
    • Sanofi
    • Bausch Health Companies Inc.
    • BioCell Technology LLC
    • Abbott Laboratories. 

North America to Dominate Global Market; Asia Pacific to Offer Growth Opportunities

  • In terms of region, the global collagen and HA-based biomaterials market has been segmented into North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa. North America is projected to account for a leading share of the global collagen and HA-based biomaterials market during the forecast period.
  • Early adoption and growing popularity of bovine and HA-based fillers in the U.S. and Canada, and rapid increase in market penetration of new players with novel collagen and HA-based biomaterials are estimated to drive the collagen and HA-based biomaterials market in North America.
  • The collagen and HA-based biomaterials market in Asia Pacific is projected to grow at a rapid pace during the forecast period. India and China are anticipated to be lucrative markets for collagen and HA-based biomaterials during the forecast period. This can be attributed to the increase in the burden of joint disorders such as knee osteoarthritis, as well as chronic diseases such as diabetes, in these countries.
  • Increase in cosmetic procedures in Japan is projected to boost the collagen and HA-based biomaterials market in Asia Pacific during the forecast period.

Global Collagen and HA-based Biomaterials Market – Segmentation

Type

Urinary Incontinence

Corneal Shields

Facial Aesthetic Dermal Fillers

Wound Dressings

Others

Application

Food

Medicine

Cosmetics

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of collagen and HA-based biomaterials market?

Collagen and HA-based biomaterials market is anticipated to reach a value of ~US$ 9.7 Bn by 2027

What is the anticipated CAGR of the collagen and HA-based biomaterials market in the forecast period?

Collagen and HA-based biomaterials market to expand at a CAGR of ~5% from 2019 to 2027

What are the key driving factors for the growth of the collagen and HA-based biomaterials market?

Collagen and HA-based biomaterials market is driven by rise in cosmetic procedures across the globe.

Which is the rising prominent segment in the collagen and HA-based biomaterials market?

The facial aesthetic dermal fillers segment dominated the global collagen and HA-based biomaterials market, and the trend is anticipated to continue during the forecast period.

Who are the key players in the collagen and HA-based biomaterials market?

Key players in the global collagen and HA-based biomaterials market include Galderma Laboratories L.P. (Nestle Skin Health), Allergan plc, Collagen Solutions Plc, Anika Therapeutics, Inc., Johnson & Johnson Services, Inc.

    1. Preface 

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Collagen and HA-based Biomaterials Market

    4. Market Overview

        4.1. Introduction

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Collagen and HA-based Biomaterials Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

        4.5. Porter’s Five Force Analysis

    5. Market Outlook

        5.1. Key Industry Developments 

        5.2. Major Research Institutes Involved 

        5.3. Technological Advancements

        5.4. Key Mergers & Acquisitions

        5.5. Pricing Analysis

    6. Global Collagen and HA-based Biomaterials Market Value and Forecast, by Type 

        6.1. Introduction & Definition 

        6.2. Global Collagen and HA-based Biomaterials Market Value (US$ Mn)Forecast, by Type, 2017–2027

            6.2.1. Urinary Incontinence

            6.2.2. Corneal Shields

            6.2.3. Facial Aesthetic Dermal Fillers

            6.2.4. Wound Dressings

            6.2.5. Others

        6.3. Global Collagen and HA-based Biomaterials Market Attractiveness, by Type

    7. Global Collagen and HA-based Biomaterials Market Value and Forecast, by Application 

        7.1. Introduction 

        7.2. Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

            7.2.1. Food

            7.2.2. Medicine

            7.2.3. Cosmetics

            7.2.4. Others

        7.3. Global Collagen and HA-based Biomaterials Market Attractiveness, by Application

    8. Global Collagen and HA-based Biomaterials Market Value and Forecast, by Region

        8.1. Introduction 

        8.2. Collagen and HA-based biomaterials Market Value (US$ Mn) Forecast, by Region, 2017–2027

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa  

        8.3. Global Collagen and HA-based Biomaterials Market Attractiveness, by Region

    9. North America Collagen and HA-based Biomaterials Market Analysis and Forecast 

        9.1. Introduction

        9.2. North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

            9.2.1. Urinary Incontinence

            9.2.2. Corneal Shields

            9.2.3. Facial Aesthetic Dermal Fillers

            9.2.4. Wound Dressings

            9.2.5. Others

        9.3. North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

            9.3.1. Food

            9.3.2. Medicine

            9.3.3. Cosmetics

            9.3.4. Others

        9.4. North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            9.4.1. U.S.

            9.4.2. Canada

        9.5. North America Collagen and HA-based Biomaterials Market Attractiveness Analysis

            9.5.1. By Type

            9.5.2. By Application 

            9.5.3. By Country/Sub-region

    10. Europe Collagen and HA-based Biomaterials Market Analysis and Forecast 

        10.1. Introduction

        10.2. Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

            10.2.1. Urinary Incontinence

            10.2.2. Corneal Shields

            10.2.3. Facial Aesthetic Dermal Fillers

            10.2.4. Wound Dressings

            10.2.5. Others

        10.3. Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

            10.3.1. Food

            10.3.2. Medicine

            10.3.3. Cosmetics

            10.3.4. Others

        10.4. Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy 

            10.4.6. Rest of Europe

        10.5. Europe Collagen and HA-based Biomaterials Market Attractiveness Analysis

            10.5.1. By Type

            10.5.2. By Application 

            10.5.3. By Country/Sub-region

    11. Asia Pacific Collagen and HA-based Biomaterials Market Analysis and Forecast 

        11.1. Introduction

        11.2. Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

            11.2.1. Urinary Incontinence

            11.2.2. Corneal Shields

            11.2.3. Facial Aesthetic Dermal Fillers

            11.2.4. Wound Dressings

            11.2.5. Others

        11.3. Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

            11.3.1. Food

            11.3.2. Medicine

            11.3.3. Cosmetics

            11.3.4. Others

        11.4. Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            11.4.1. Japan

            11.4.2. China

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Asia Pacific Collagen and HA-based Biomaterials Market Attractiveness Analysis

            11.5.1. By Type

            11.5.2. By Application 

            11.5.3. By Country/Sub-region

    12. Latin America  Collagen and HA-based biomaterials Market Analysis and Forecast 

        12.1. Introduction

        12.2. Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

            12.2.1. Urinary Incontinence

            12.2.2. Corneal Shields

            12.2.3. Facial Aesthetic Dermal Fillers

            12.2.4. Wound Dressings

            12.2.5. Others

        12.3. Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

            12.3.1. Food

            12.3.2. Medicine

            12.3.3. Cosmetics

            12.3.4. Others

        12.4. Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Latin America Collagen and HA-based Biomaterials Market Attractiveness Analysis

            12.5.1. By Type

            12.5.2. By Application 

            12.5.3. By Country/Sub-region

    13. Middle East & Africa  Collagen and HA-based biomaterials Market Analysis and Forecast 

        13.1. Introduction

        13.2. Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

            13.2.1. Urinary Incontinence

            13.2.2. Corneal Shields

            13.2.3. Facial Aesthetic Dermal Fillers

            13.2.4. Wound Dressings

            13.2.5. Others

        13.3. Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

            13.3.1. Food

            13.3.2. Medicine

            13.3.3. Cosmetics

            13.3.4. Others

        13.4. Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Middle East & Africa Collagen and HA-based Biomaterials Market Attractiveness Analysis

            13.5.1. By Type

            13.5.2. By Application 

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player – Competition Matrix (By Tier and Size of companies)

        14.2. Global Collagen and HA-based Biomaterials Market Share Analysis, by Company (2018)

        14.3. Company Profiles

            14.3.1. Collagen Solutions Plc

                14.3.1.1. Company Description

                14.3.1.2. Business Overview

                14.3.1.3. Financial Overview

                14.3.1.4. Strategic Overview

                14.3.1.5. SWOT Analysis

            14.3.2. Sanofi

                14.3.2.1. Company Description

                14.3.2.2. Business Overview

                14.3.2.3. Financial Overview

                14.3.2.4. Strategic Overview

                14.3.2.5. SWOT Analysis

            14.3.3. Allergan plc 

                14.3.3.1. Company Description

                14.3.3.2. Business Overview

                14.3.3.3. Financial Overview

                14.3.3.4. Strategic Overview

                14.3.3.5. SWOT Analysis

            14.3.4. Anika Therapeutics, Inc.

                14.3.4.1. Company Description

                14.3.4.2. Business Overview

                14.3.4.3. Financial Overview

                14.3.4.4. Strategic Overview

                14.3.4.5. SWOT Analysis

            14.3.5. Bausch Health Companies Inc.

                14.3.5.1. Company Description

                14.3.5.2. Business Overview

                14.3.5.3. Financial Overview

                14.3.5.4. Strategic Overview

                14.3.5.5. SWOT Analysis

            14.3.6. Abbott Laboratories

                14.3.6.1. Company Description

                14.3.6.2. Business Overview

                14.3.6.3. Financial Overview

                14.3.6.4. Strategic Overview

                14.3.6.5. SWOT Analysis

            14.3.7. Johnson & Johnson Services, Inc.

                14.3.7.1. Company Description

                14.3.7.2. Business Overview

                14.3.7.3. Financial Overview

                14.3.7.4. Strategic Overview

                14.3.7.5. SWOT Analysis

            14.3.8. Galderma Laboratories L.P. (Nestle Skin Health) 

                14.3.8.1. Company Description

                14.3.8.2. Business Overview

                14.3.8.3. Financial Overview

                14.3.8.4. Strategic Overview

                14.3.8.5. SWOT Analysis

            14.3.9. BioCell Technology LLC 

                14.3.9.1. Company Description

                14.3.9.2. Business Overview

                14.3.9.3. Financial Overview

                14.3.9.4. Strategic Overview

                14.3.9.5. SWOT Analysis

    List of Tables

    Table 01: List of Research Institutes

    Table 02: Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

    Table 03: Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 04: Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Region, 2017–2027

    Table 05: North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 06: North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

    Table 07: North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017?2027

    Table 08: Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region,

    Table 09: Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

    Table 10: Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017?2027

    Table 11: Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 12: Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

    Table 13: Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017?2027

    Table 14: Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 15: Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

    Table 16: Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017?2027

    Table 17: Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by

    Table 18: Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type,

    Table 19: Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017?2027

    List of Figures

    Figure 01: Global Collagen and HA-based Biomaterials Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2027

    Figure 02: Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, 2017–2027

    Figure 03: Global Collagen and HA-based Biomaterials Market Value Share (%), by Type, 2018

    Figure 04: Global Collagen and HA-based Biomaterials Market Value Share (%), by Application, 2018

    Figure 05: Global Collagen and HA-based Biomaterials Market Value Share (%), by Region, 2018

    Figure 07: Evolution of Dermal Fillers

    Figure 08: Technological Advances – Dermal Fillers

    Figure 09: Key Mergers & Acquisitions

    Figure 10: Global Collagen and HA-based Biomaterials Market Value Share (%), by Type, 2018 and 2027

    Figure 11: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urinary Incontinence, 2017–2027

    Figure 12: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corneal Shields, 2017–2027

    Figure 13: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Facial Aesthetic Dermal Fillers, 2017–2027

    Figure 14: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Wound Dressings, 2017–2027

    Figure 15: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

    Figure 16: Global Collagen and HA-based Biomaterials Market Attractiveness, by Type, 2019–2027

    Figure 17: Global Collagen and HA-based Biomaterials Market Value Share (%), by Application, 2018 and 2027

    Figure 18: Global Collagen and HA-based Biomaterials Market Attractiveness, by Application, 2019–2027

    Figure 19: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Food, 2017–2027

    Figure 20: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Medicine, 2017–2027

    Figure 21: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cosmetics, 2017–2027

    Figure 22 Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

    Figure 23: Global Collagen and HA-based Biomaterials Market Value Share Analysis, by Region, 2018 and 2027

    Figure 24: Global Collagen and HA-based Biomaterials Market Attractiveness Analysis, by Region, 2019–2027

    Figure 25: North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 26: North America Collagen and HA-based Biomaterials Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 27: North America Collagen and HA-based Biomaterials Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 28: North America Collagen and HA-based Biomaterials Market Value Share (%), by Type, 2018 and 2027

    Figure 29: North America Collagen and HA-based Biomaterials Market Attractiveness, by Type, 2019–2027

    Figure 30: North America Collagen and HA-based Biomaterials Market Value Share (%), by Application, 2018 and 2027

    Figure 31: North America Collagen and HA-based Biomaterials Market Attractiveness, by Application, 2019–2027

    Figure 32: Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 33: Europe Collagen and HA-based Biomaterials Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 34: Europe Collagen and HA-based Biomaterials Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 35: Europe Collagen and HA-based Biomaterials Market Value Share (%), by Type, 2018 and 2027

    Figure 36: Europe Collagen and HA-based Biomaterials Market Attractiveness, by Type, 2019–2027

    Figure 37: Europe Collagen and HA-based Biomaterials Market Value Share (%), by Application, 2018 and 2027

    Figure 38: Europe Collagen and HA-based Biomaterials Market Attractiveness, by Application, 2019–2027

    Figure 39: Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 40: Asia Pacific Collagen and HA-based Biomaterials Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 41: Asia Pacific Collagen and HA-based Biomaterials Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 42: Asia Pacific Collagen and HA-based Biomaterials Market Value Share (%), by Type, 2018 and 2027

    Figure 43: Asia Pacific Collagen and HA-based Biomaterials Market Attractiveness, by Type, 2019–2027

    Figure 44: Asia Pacific Collagen and HA-based Biomaterials Market Value Share (%), by Application, 2018 and 2027

    Figure 45: Asia Pacific Collagen and HA-based Biomaterials Market Attractiveness, by Application, 2019–2027

    Figure 46: Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 47: Latin America Collagen and HA-based Biomaterials Market Value Share Analysis, by Country/Sub-region,

    Figure 48: Latin America Collagen and HA-based Biomaterials Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 49: Latin America Collagen and HA-based Biomaterials Market Value Share (%), by Type, 2018 and 2027

    Figure 50: Latin America Collagen and HA-based Biomaterials Market Attractiveness, by Type, 2019–2027

    Figure 51: Latin America Collagen and HA-based Biomaterials Market Value Share (%), by Application, 2018 and 2027

    Figure 52: Latin America Collagen and HA-based Biomaterials Market Attractiveness, by Application, 2019–2027

    Figure 53: Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 54: Middle East & Africa Collagen and HA-based Biomaterials Market Value Share Analysis, by

    Figure 55: Middle East & Africa Collagen and HA-based Biomaterials Market Attractiveness Analysis, by

    Figure 56: Middle East & Africa Collagen and HA-based Biomaterials Market Value Share (%), by Type, 2018 and 2027

    Figure 57: Middle East & Africa Collagen and HA-based Biomaterials Market Attractiveness, by Type, 2019–2027

    Figure 58: Middle East & Africa Collagen and HA-based Biomaterials Market Value Share (%), by Application,

    Figure 59: Middle East & Africa Collagen and HA-based Biomaterials Market Attractiveness, by Application, 2019–2027

    Figure 60: Global Collagen and HA-based Biomaterials Market Share, by Company, 2018

    Figure 61: Collagen Solutions Plc, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 62: Collagen Solutions Plc, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018

    Figure 63: Collagen Solutions Plc, Breakdown of Net Sales (%), by Region, 2018

    Figure 64: Sanofi, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018

    Figure 65: Sanofi, Breakdown of Net Sales (%), by Business Segment, 2018

    Figure 66: Sanofi, Breakdown of Net Sales (%), by Geography, 2018

    Figure 67: Sanofi, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018

    Figure 68: Allergan plc, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 69: Allergan plc, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018

    Figure 70: Allergan plc, Breakdown of Net Sales (%), by Product & Region, 2018

    Figure 71: Anika Therapeutics, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018

    Figure 72: Anika Therapeutics, Inc., Breakdown of Net Sales (%), by Business Segment, 2018

    Figure 73: Anika Therapeutics, Inc., Breakdown of Net Sales (%), by Geography, 2018

    Figure 74: Anika Therapeutics, Inc., R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018

    Figure 75: Bausch Health Companies Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

    Figure 76: Bausch Health Companies Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017

    Figure 77: Bausch Health Companies Inc., Breakdown of Net Sales, by Region, 2017

    Figure 78: Bausch Health Companies Inc., Breakdown of Net Sales, by Business Segment, 2017

    Figure 79: Abbott Laboratories, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 80: Abbott Laboratories, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 81: Abbott Laboratories, Breakdown of Net Sales, by Region, 2017

    Figure 82: Abbott Laboratories, Breakdown of Net Sales, by Business Segment, 2018

    Figure 83: Johnson & Johnson, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

    Figure 84: Johnson & Johnson Breakdown of Net Sales (%), by Business Segment, 2018

    Figure 85: Johnson & Johnson, Breakdown of Net Sales (%), by Region, 2018

    Figure 86: Johnson and Johnson R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018 

Copyright © Transparency Market Research, Inc. All Rights reserved

Collagen and HA-based Biomaterials Market

Schedule a Call